| abstract |
The present invention relates to a peroxisome proliferator activated receptor agonist comprising a compound represented by the following general formula (I), a non-toxic salt thereof or a hydrate thereof and an active ingredient thereof.n n n Formula In n n n n n n n (Wherein all symbols are as defined in the specification).n n n The compound represented by the formula (I) has an effect of controlling the PPAR receptor and is useful as an antidiabetic agent, a lipid lowering agent, a metabolic disorder such as diabetes, obesity, syndrome X, hypercholesterolemia and hypercholesterolemia, hyperlipidemia, , HDL cholesterol enhancers, LDL cholesterol and / or VLDL cholesterol lowering agents, and diabetic or syndrome X risk factors. |